Malaysia Pharmaceutical Company Investment

Date：18 May 2026

Print
A+
A
A-

In February 2026, Silk Road Fund and Quadria Capital, a healthcare-focused private equity fund in Southeast Asia, jointly completed the privatization and acquisition of Apex Healthcare, a leading private pharmaceutical company in Malaysia. As the third largest pharmaceutical firm in the country, Apex Healthcare both manufactures and distributes pharmaceutical and healthcare products. This investment helps enhance Southeast Asian people’s access to medicines, improving their well-being and continuously advancing the Health Silk Road.